Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays
The grant opportunity is focused on addressing adherence to antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) for HIV treatment and prevention, a significant barrier despite advancements in medication formulations. There are anticipated 1 to 3 awards with a funding of $306,872 for Phase I (up to 1 year) and $2,045,816 for Phase II (up to 2 years). The aim is to develop methods f…
(Fast-Track and Direct-to-Phase II proposals will not be accepted)\nNumber of anticipated awards: 1-3\nBudget (total costs):\nPhase I: $ 306,872 for up to 1 year;\nPhase II: $ 2,045,816 for up to 2 years.\nBackground\nAccording to the Centers for Disease Control and Prevention (CDC), HIV remains…
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers